Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-02 04:07:50 - browse：64831

Stock exchange — Drew Angerer/Getty Images

Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

“We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： FDA rejects Alnylam's heart disease treatment over insufficient data

knowledge

WSS

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Senate panel eyes new effort on drug shortages

The future of health care in the House

AstraZeneca to buy developer of next

A virus, fished out of a lake, may have saved a man’s life

Analysis of telehealth claims data suggest service duplication

knowledge

Wikipedia

focus

Medicare details structure of new drug price negotiation program

UnitedHealth increases loan offers after Change Healthcare outage

Psychedelics group wrestles with new pharma identity

Was Amgen transparent enough on FDA's concern on cancer drug?

Guidelines to prevent youth baseball injuries need more muscle

AI can decode, harness the power of the humane immune system

Jerome Adams on the need for new antivirals for Covid

The future of health care in the House

At least 13 dead in Texas as scorching temps continue

FDA panel signals lack of confidence in Amgen cancer drug data

focus

Chan Zuckerberg Biohub Chicago to focus on inflammation

Stop the failed accountable care organization experiment

Was Amgen transparent enough on FDA's concern on cancer drug?

The future of health care in the House

Stop the failed accountable care organization experiment

Intermittent fasting comes with a heart risk? Not so fast

Wikipedia

knowledge

hotspot

focus